Company identity
Browse spinoutsCompany number 14690230
Company profile
UK company 14690230, incorporated on 27 February 2023.
Crucible Therapeutics Limited is a UK company with status Active founded in 2023.
Company number 14690230
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
Crucible Therapeutics develops gene therapy to treat neurodegenerative diseases.
The company is sponsoring research contracts for two post-doctoral researchers at the University of Sheffield and outsource reagents and research from various CDMOs internationnally. It is currently operating at pre-clinical level.
Young company established in September 2023